# Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)

> **NCT01882920** · NA · COMPLETED · sponsor: **Regina Elena Cancer Institute** · enrollment: 80 (actual)

## Conditions studied

- Primary Peritoneal Neoplasm
- Secondary Peritoneal Neoplasm

## Interventions

- **DRUG:** Goal Directed Intravenous Restrictive Fluid Therapy
- **DRUG:** Conventional Intravenous Fluid therapy

## Key facts

- **NCT ID:** NCT01882920
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-06
- **Final completion:** 2012-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01882920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01882920, "Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01882920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*